Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
I believe that if cancer survivors live long enough, the majority will develop late onset chemotherapy-induced heart failure- cardiomyopathy, AFib, High BP, DVT aka Blood clots-
I have chemotherapy-induced heart failure. I’m a long-term cancer survivor. Before my conventional cancer treatment I had a healthy lifestyle, a healthy heart, normal BP, never a blood clot, etc. I underwent treatment for my blood cancer at one of the finest hospitals in the United States (I thought).
During my induction therapy I developed a blood clot (DVT). In late 2010 I developed chronic atrial fibrillation (Afib). In early 2019 I was diagnosed with chemotherapy-induced cardiomyopathy (CIC). When my traditionally low blood pressure hit 130/90 in early 2019, I began a diet, exercise, supplement program to reduce my HBP.
The article linked below authored by the Mayo Clinic strikes the tone I’ve come to expect from conventional oncology. The author makes it sound like the cancer patient may develop heart failure if he/she has heart problems to begin with. And chemotherapy may have a negative impact, maybe…
In fact, my heart failure, my chronic A-fib, ejection-fraction, all are improving. And I have never taken any conventional medication for any of it. I’m not saying that my:
are NOT curative therapies for all of the heart damage I sustained between my diagnosis in 1994 and the completion of these therapies in late 1996. I’m saying my heart therapies are complementary therapies. These evidence-based, non-toxic therapies complement heart, blood thinning, hypertension, etc. therapies.
Having lived with a series of short, long-term and late stage side effects, my conclusion is that while conventional oncology has a place in the identification and treatment of cancer, that the side effects caused by conventional, FDA approved treatments cause a host of side effects that increase our risk of pain and mortality.
If you have any questions or comments about your own situation please scroll down the page, post a question or a comment and I will reply to you ASAP.
“Yes, some conventional chemotherapy drugs used to treat cancer can increase your risk of heart failure. Heart problems can also happen with newer targeted therapy drugs and with radiation therapy.
Examples of heart-related problems that can happen with cancer treatments include:
Whether you’re at risk for heart problems during and after cancer treatment depends on how healthy your heart is and the specific drugs you’ll be receiving. Some drugs may carry a higher risk of heart problems in people who already have heart problems. Sometimes the risk is higher if you take a higher dose of the drug.
If your doctor is considering a cancer treatment that may affect your heart, you may undergo heart function testing before starting treatment. If you have a preexisting heart condition, such as cardiomyopathy, your doctor might suggest a different type of chemotherapy.
You may need periodic heart monitoring during treatment, depending on the type of chemotherapy you receive. Monitoring might continue after treatment, too.
Cancer doctors (oncologists) and heart doctors (cardiologists) sometimes work together to provide care for people who have a risk of heart problems during and after cancer treatment. This area of medicine is sometimes referred to as cardio-oncology.”
“Hypertension has been reported to be the most common comorbidity encountered in patients with malignancy (37%).1 Its prevalence before chemotherapy is similar to that in the general population (29%).2
The much higher rate is observed after the initiation of certain chemotherapeutic agents (angiogenesis inhibitors, 17%–80%; alkylating agents, 36%–39%; and immunosuppressants after stem-cell transplantation, 30%–80%).3–5…
Hypertension and heart failure is emerging as one of the most common side effects of these agents. These drugs include the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab and certain tyrosine kinase inhibitors (sunitinib, sorafenib, and pazopanib).
The incidence of de novo or worsening hypertension in association with these drugs varies between 17% and 80%…
In the absence of a proven single dominant mechanism, it is likely that the real cause is a combination of several of these suggested mechanisms…
In the absence of clinical data to suggest otherwise, the management of other causes of cancer-treatment–related hypertension should also follow the JNC 7 guidelines.
New or worsening hypertension is commonly encountered in cancer patients. Causes include many of the therapeutic agents used to care for these patients. Diagnosis and treatment should follow the JNC 7 guidelines. The aim is to minimize the risk of end-organ damage and to enable the continuation of needed cancer therapy. A team approach involving collaborative efforts between oncologists and other specialists (internists, cardiologists, and nephrologists) is encouraged for optimal management of this comorbidity.”
Impact of Blood Clots on the United States
Know the Lingo About Blood Clots
DVT and PE are also known as VTE (venous thromboembolism).
Blood Clots Affect Many People
Blood Clots Can Be Deadly
Blood Clots Are Costly
Things to Know
For more information, please visit: cdc.gov/ncbddd/dvt/index.html